Publications Database

Aman M. G. et al. (2015)

Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial.

Journal of Child and Adolescent Psychopharmacology

August, 25(6), pp. 482-493.

Read Abstract (New Window) Read Full (New Window)

Anagnostou E. et al.

Metformin for treatment of overweight induced by atypical antipsychotic medication in young people with autism spectrum disorder: A randomized clinical trial.

JAMA Psychiatry

Read Abstract (New Window)

Bhatti I. et al. (2013)

A retrospective study of amitriptyline in youth with autism spectrum disorders.

Journal of Autism and Developmental Disorders

43(5), pp. 1017-1027.

Read Abstract (New Window)

Dhillon S. , Hellings J. A. , Butler M. G. (2011)

Genetics and mitochondrial abnormalities in autism spectrum disorders: a review.

Current Genomics

August, 12(5), pp. 322-332

Read Abstract (New Window) Read Full (New Window)

Handen B. L. et al. (2015)

Atomoxetine, parent training, and their combination in children with autism spectrum disorder and attention deficit hyperactivity disorder.

Journal of the American Academy of Child and Adolescent Psychiatry

November, 54(11), pp. 905-915.

Read Abstract (New Window)

Hellings J. A. et al. (2006)

A crossover study of risperidone in children, adolescents and adults with mental retardation.

Journal of Autism and Developmental Disorders

36(3), pp. 401-411

Read Abstract (New Window)

Hellings J. A. , Arnold L. E. , Han J. C. (2017)

Dopamine antagonists for treatment resistance in autism spectrum disorders: review and focus on BDNF stimulators loxapine and amitriptyline.

Experimental and Clinical Psychopharmacology

18(6), pp. 581-588.

Read Abstract (New Window)

Hellings J. A. et al. (2011)

Long-term aripiprazole in youth with developmental disabilities including autism.

Journal of Mental Health Research in Intellectual Disabilities

4(1), pp. 40–52.

Read Abstract (New Window)

Hellings J. A. et al. (2015)

Loxapine add-on for adolescents and adults with autism spectrum disorders and irritability.

Journal of Child and Adolescent Psychopharmacology

25(2), pp. 150–159.

Read Abstract (New Window)

Hellings J. A. et al. (1996)

Sertraline response in adults with mental retardation and autistic disorder

Journal of Clinical Psychiatry

57(8), pp. 333-336

Read Abstract (New Window)

Hellings J. A. et al. (2001)

Weight gain in a controlled study of risperidone in children, adolescents and adults with mental retardation and autism.

Journal of Child and Adolescent Psychopharmacology

11(3), pp. 229-238

Read Abstract (New Window)

Jain S. , Andridge R. , Hellings J. A. (2016)

Loxapine for reversal of antipsychotic-induced metabolic disturbances: A chart review.

Journal of Autism and Developmental Disorders

April, 46(4), pp.1344-1353.

Read Abstract (New Window)

Smith T. et al. (2016)

Atomoxetine and parent training for children with autism and attention-deficit-hyperactivity disorder: A 24-week extension study.

Journal of the Canadian Academy of Child and Adolescent Psychiatry

October, 55(10),

Read Abstract (New Window)

Valdovinos M. G. et al. (2002)

Multimodal evaluation of risperidone for destructive behavior: functional analysis, direct observations, rating scales, and psychiatric impressions.

Experimental and Clinical Psychopharmacology

10(3), pp. 268-275

Read Abstract (New Window)

Zarcone J. R. et al. (2001)

Effects of risperidone on aberrant behavior of persons with developmental disabilities: I: A double-blind crossover studies using multiple measures.

American Journal on Mental Retardation

November, 106(6), pp. 525-538.

Read Abstract (New Window)